CVS and Eli Lilly strike partnership on GLP-1 access
The deal was announced alongside second-quarter results in which both companies exceeded Wall Street expectations.
TR
By Tom Reyes · Markets Editor
Aug 5 03:00 ETSource: Yahoo Finance
The wire
- 01CVS and Eli Lilly said they formed a partnership aimed at improving access to GLP-1 medicines, disclosed as both companies topped second-quarter estimates.
- 02Pharmacy and telehealth operators watch payer-manufacturer arrangements closely because they shape formulary placement and cash-pay pricing for semaglutide and tirzepatide alternatives.
- 03Terms, covered products and start date were not detailed in the report.
From the source
Read at finance.yahoo.comCVS, Eli Lilly Forge Partnership on Improved GLP-1 Access; Companies Top Second-Quarter Views
